Belvedere Trading’s bluebird bio BLUE Stock Holding History

Belvedere Trading’s Portfolio BLUE Stock Details BLUE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-10,300	Closed	-$50.3K	–	838
2025 Q1	$50.3K	Buy	+10,300	New	+$61.9K	﹤0.01%	491
2024 Q1	–	Sell	-3,370	Closed	-$93K	–	715
2023 Q4	$93K	Buy	+3,370	New	+$205K	﹤0.01%	475
2023 Q1	–	Sell	-685	Closed	-$94.8K	–	961
2022 Q4	$94.8K	Buy	+685	New	+$96.5K	﹤0.01%	492

Other funds holding BLUE

Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Belvedere Trading's BLUE Position: Q1 2024 in Review

Belvedere Trading sold out of bluebird bio (BLUE) in Q1 2024, closing a stake of 86 shares — an estimated $2.36K sold.

Belvedere Trading first reported a position in BLUE in Q1 2022 and held it in 5 quarters. The position peaked at $646K in Q3 2022. 158 funds tracked by Wall St. Rank hold BLUE as of Q1 2024.

Belvedere Trading reported no remaining bluebird bio position as of Q1 2024 after selling out during the quarter.
Belvedere Trading sold 86 bluebird bio shares in Q1 2024, an estimated $2.36K.
Belvedere Trading first reported a position in bluebird bio in Q1 2022 and held it in 5 quarters.
Belvedere Trading's bluebird bio position peaked at $646K in Q3 2022.
158 funds tracked by Wall St. Rank held bluebird bio as of Q1 2024.

Based on Belvedere Trading's 13F filing for Q1 2024, filed 9 May 2024.